O40. PTSD Augmented Psychotherapy With Ketamine (KPE) - First Results

      Augmenting prolonged exposure (PE) with pharmacotherapy has been suggested as a promising solution to address treatment-resistant PTSD and high dropout rates. Ketamine has been shown to have rapid-acting effects on treatment resistant depression following single infusion and with neurogenesis, that may promote new learning. We present first results of ketamine augmentation of intensive 7-day-PE (KPE) for PTSD patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect